Cookie Policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read ourPrivacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

 

 

First patient enrolled in major new study investigating abbreviated DAPT post-stent in high bleeding risk patientshttp://www.terumo-europe.com/en-emea/news/first-patient-enrolled-in-major-new-study-investigating-abbreviated-dapt-post-stent-in-high-bleeding-risk-patientsFirst patient enrolled in major new study investigating abbreviated DAPT post-stent in high bleeding risk patientsEmmen, The Netherlands03/04/2017 22:00:00
Terumo announces first commercial clinical case using QuiremSpheres®http://www.terumo-europe.com/en-emea/news/terumo-announces-first-commercial-clinical-case-using-quiremspheres®Terumo announces first commercial clinical case using QuiremSpheres®Leuven, Belgium27/03/2017 22:00:00
Terumo and Toxikon Europe NV announce a strategic partnershiphttp://www.terumo-europe.com/en-emea/news/terumo-and-toxikon-europe-nv-announce-a-strategic-partnershipTerumo and Toxikon Europe NV announce a strategic partnershipLeuven, Belgium05/03/2017 23:00:00

 

 

TOPIC 2017http://www.terumo-europe.com/en-emea/Events/TOPIC 2017.aspxTOPIC 2017Japan19/07/2017 22:00:0022/07/2017 12:24:00Tokyohttp://www.topic.gr.jp/english/, http://www.topic.gr.jp/english/
ESC 2017http://www.terumo-europe.com/en-emea/Events/ESC 2017.aspxESC 2017Spain25/08/2017 22:00:0030/08/2017 12:29:00Barcelonahttp://www.escardio.org/, http://www.escardio.org/